Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Jun 8;74(2):291–302. doi: 10.1007/s00280-014-2503-z

Fig. 2.

Fig. 2

T-dCyd and aza-T-dCyd induce DNMT1 depletion in leukemia cells and in solid tumor cells. Exponentially growing leukemia cells (a CCRF-CEM, upper panel and KG1a, lower panel) or solid tumor cells (b NCI-H23 lung carcinoma, HCT-116 colon carcinoma or IGROV-1 ovarian carcinoma cells) were exposed to indicated concentrations of either T-dCyd or aza-T-dCyd for 96 h. Cell lysates were fractionated on SDS-PAGE gels and were analyzed by Western blotting using antibodies against DNMT1 or GAPDH